Product details:
| ISBN13: | 9780443193507 |
| ISBN10: | 0443193509 |
| Binding: | Hardback |
| No. of pages: | 488 pages |
| Size: | 229x152 mm |
| Language: | English |
| 700 |
Category:
Immunology for Engineers
Publisher: Academic Press
Date of Publication: 1 May 2024
Normal price:
Publisher's listprice:
EUR 122.00
EUR 122.00
Your price:
40 275 (38 357 HUF + 5% VAT )
discount is: 20% (approx 10 069 HUF off)
Discount is valid until: 30 June 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
Not yet published.
Long description:
Immunology for Engineers, Volume 140 consists of chapters from stalwarts of the field, covering topics such as antibody engineering, adjuvant requirement and its methodology for assessment, and the need to develop immunotherapy, etc. Chapters covered in this volume discuss Current Status and Future Prospective of Breast Cancer Immunotherapy, Engineering high affinity antigen binders- beyond antibodies, Platelets and Inter-Cellular Communication in Immune Responses: Dialogue with both Professional and Non-Professional Immune Cells, Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapy: A boon for cancer-free life, and Molecular insights and promise of Oncolytic Virus based Immunotherapy.
- Presents the latest in immunological engineering
- Delves into timely topics such as antibody engineering
- Covers vaccine engineering amongst many other important topics
Table of Contents:
1. Preface
Vijay Kumar Prapajati
2. Current Status and Future Prospective of Breast Cancer Immunotherapy
Anurag S. Rathore
3. Engineering high affinity antigen binders- beyond antibodies
Rajeev Kumar Pandey
4. Platelets and Inter-Cellular Communication in Immune Responses: Dialogue with both Professional and Non-Professional Immune Cells
Sunil Kumar SINGH
5. Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapy: A boon for cancer-free life
Bajarang Vasant Kumbhar
6. Molecular insights and promise of Oncolytic Virus based Immunotherapy
Balachandar Vellingiri
Vijay Kumar Prapajati
2. Current Status and Future Prospective of Breast Cancer Immunotherapy
Anurag S. Rathore
3. Engineering high affinity antigen binders- beyond antibodies
Rajeev Kumar Pandey
4. Platelets and Inter-Cellular Communication in Immune Responses: Dialogue with both Professional and Non-Professional Immune Cells
Sunil Kumar SINGH
5. Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapy: A boon for cancer-free life
Bajarang Vasant Kumbhar
6. Molecular insights and promise of Oncolytic Virus based Immunotherapy
Balachandar Vellingiri